Previous research has highlighted the pivotal role of BIRC5 in HCC and its potential for targeted cancer treatment (Kondapuram et al. 2023; Frazzi 2021; Albadari and Li 2023). Here, BIRC5 is linked to hepatocellular carcinoma.